These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5290700)

  • 1. The latex flocculation inhibition test for the detection of fibrin(ogen) degradation products.
    Allington MJ
    Scand J Haematol Suppl; 1971; 13():389-90. PubMed ID: 5290700
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of fibrin(ogen) degradation products by a latex clumping method.
    Allington MJ
    Scand J Haematol Suppl; 1971; 13():115-9. PubMed ID: 5290675
    [No Abstract]   [Full Text] [Related]  

  • 3. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
    Garvey MB; Black JM
    J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
    Kroneman H; Nieuwenhuizen W; Knot EA
    Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic pattern and reactivity of fibrinogen degradation products (FDP) in three assays.
    Niewiarowski S; Nandi M; Colman RW; Bloch KJ
    Scand J Haematol Suppl; 1971; 13():129-35. PubMed ID: 4258198
    [No Abstract]   [Full Text] [Related]  

  • 6. Latex-bound antifibrinogen test for plasma fibrinogen assay.
    Castelan DJ; Hirsh J; Martin M
    J Clin Pathol; 1968 Sep; 21(5):638-42. PubMed ID: 5697369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of fibrinogen degradation products by use of antibody coated latex particles. The possibilities and limits of the method.
    Melliger EJ
    Thromb Diath Haemorrh; 1970 May; 23(2):211-27. PubMed ID: 4193323
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.
    Marder VJ; Matchett MO; Sherry S
    Am J Med; 1971 Jul; 51(1):71-82. PubMed ID: 4998883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of disseminated intravascular coagulation: the value of soluble fibrin, D-dimers and fibrin(ogen) split products].
    Wieding JU; Eisinger G; Köstering H
    Klin Wochenschr; 1989 Aug; 67(15):764-73. PubMed ID: 2770191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
    Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
    Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen.
    Jespersen J; Sidelmann J
    Acta Haematol; 1982; 67(1):2-7. PubMed ID: 6800197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
    Bach-Gansmo ET; Godal HC; Skjønsberg OH
    Thromb Res; 1998 Nov; 92(3):125-34. PubMed ID: 9806364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of methods for the detection and quantitation of serum fibrin-fibrinogen degradation products.
    Erickson C; String T; Stewart D; Cohen RJ
    Am J Clin Pathol; 1972 Oct; 58(4):394-9. PubMed ID: 4674336
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
    Connaghan DG; Francis CW; Ryan DH; Marder VJ
    Am J Clin Pathol; 1986 Sep; 86(3):304-10. PubMed ID: 3751995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-fibrinogen degradation products in allergic disorders.
    Palma-Carlos AG; de Sá A; Joana-Geraldes M; Ducla-Soares J; Migueis-Clode MH
    Allergol Immunopathol (Madr); 1974; 2(6):419-22. PubMed ID: 4282697
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 18. A rapid latex agglutination assay for the determination of plasma fibrinogen.
    Gargan PE; Sheehan C; Williams L; Ploplis V; Hearty U; Lowry C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):465-8. PubMed ID: 2133224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Babesia bovis (argentina): analysis of fibrinogen-like proteins during infection.
    Goodger BV; Wright IG
    Z Parasitenkd; 1979 Dec; 60(3):211-20. PubMed ID: 543211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen.
    Hoffman M; Greenberg CS
    Am J Clin Pathol; 1987 Oct; 88(4):490-3. PubMed ID: 3661500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.